Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)
Clinical trial NCT06260722 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06260722
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-21
- Primary completion
- 2026-08-01
- Enrollment
- 1250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.